CTRI/2024/05/066629Not yet recruitingPhase 3
Clinical efficacy of a unique dietary formulation in type 2 diabetes. - NI
Dr.Swati Mohite0 sites0 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 3
- Status
- Not yet recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •Participants with Type 2 Diabetes mellitus on Oral Hypoglycemic Agents or insulin for at least 4 weeks that is not anticipated to change during the study.
- •Participants with Type 2 diabetes without medication
- •HbA1c = 6.5
- •Participants willing for inclusion in clinical trial.
Exclusion Criteria
- •Any neurological condition requiring urgent medical intervention.
- •Any other serious systemic disease in last 3 months.
- •Subjects having malignancies, serious infections as well as those requiring long term steroids and hormonal treatment.
- •Pregnant and lactating women.
- •Subjects having H/O renal transplant.
Investigators
Similar Trials
Completed
Not Applicable
Effect of a dietary portfolio on metabolic syndromeMetabolic syndromeNutritional, Metabolic, EndocrineISRCTN96579359Institution of Science and Technology of Mexico City (Instituto de Ciencia y Tecnología del Distrito Federal) (Mexico)97
Completed
Unknown
Exploring the benefits of grape pomace supplements for diabetic eye health: new clinical trial resultsImprovement of ophthalmic outcomes in patients with diabetic retinopathyEye DiseasesISRCTN15020073Inventia Biotech-Healthcare Food Research Center s.r.l.99
Completed
Not Applicable
Safety and efficacy of a dietary supplement containing bovine alpha S1-casein tryptic hydrolysate and Hemerocallis fulva on sleep disorders among Japanese adultssleep disordersJPRN-UMIN000013349DHC Corporation10
Completed
Not Applicable
Safety and efficacy of a dietary supplement containing Irvingia gabonensis extract.obesityJPRN-UMIN000015534DHC Corporation20
Completed
Unknown
A food supplement based on probiotics, vitamin PP and vitamin B2 can improve heartburn symptoms/dyspeptic disorders and heartburn-related quality of life in subjects with mild to moderate gastroesophageal reflux disease (GERD)ISRCTN96068143utratech Srl56